Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7838529 Xanthine derivates, their preparation and their use in pharmaceutical compositions

Patent 7838529 was granted and assigned to Boehringer Ingelheim on November, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Boehringer Ingelheim

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

78385290

Patent Inventor Names

Elke Langkopf0

Frank Himmelsbach0

Matthias Eckhardt0

Michael Mark0

Ralf Lotz0

Roland Maier0

Date of Patent

November 23, 2010

Patent Application Number

123550110

Date Filed

January 16, 2009

Patent Citations Received

‌

US Patent 11919903 Polymorphs

‌

US Patent 11911388 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug

‌

US Patent 11911387 Vasoprotective and cardioprotective antidiabetic therapy

Patent Primary Examiner

‌

Mark L. Berch

Patent abstract

Compounds of formula (I)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7838529 Xanthine derivates, their preparation and their use in pharmaceutical compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API